News
Texas Roadhouse (TXRH) Reports Q2 Earnings: What Key Metrics Have to Say
Texas Roadhouse (TXRH) reported $1.51 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 12.7%. EPS of $1.86 for the same period compares to $1.79 a year
EOG Resources (EOG) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended June 2025, EOG Resources (EOG) reported revenue of $5.48 billion, down 9.1% over the same period last year. EPS came in at $2.32, compared to $3.16 in the year-ago quarter.
The
Maplebear (CART) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, Maplebear (CART) reported revenue of $914 million, up 11.1% over the same period last year. EPS came in at $0.41, compared to $0.20 in the year-ago quarter.
The
Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Solventum (SOLV) reported $2.16 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 3.8%. EPS of $1.69 for the same period compares to $1.56 a year ago.
The
Mach Natural Resources LP (MNR) Surpasses Q2 Earnings and Revenue Estimates
Mach Natural Resources LP (MNR) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.42 per share a year ago
Diodes (DIOD) Tops Q2 Earnings and Revenue Estimates
Diodes (DIOD) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.33 per share a year ago. These figures are
GoDaddy (GDDY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, GoDaddy (GDDY) reported revenue of $1.22 billion, up 8.3% over the same period last year. EPS came in at $1.41, compared to $1.10 in the year-ago quarter.
The
HP (HPQ) Gains As Market Dips: What You Should Know
HP (HPQ) ended the recent trading session at $25.35, demonstrating a +1.36% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a loss of 0.08% for the
PTC Therapeutics (PTCT) Reports Q2 Earnings: What Key Metrics Have to Say
PTC Therapeutics (PTCT) reported $178.88 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 4.2%. EPS of -$0.83 for the same period compares to -$1.16 a
Guild Holdings Company (GHLD) Q2 Earnings Top Estimates
Guild Holdings Company (GHLD) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.49 per share a year ago
Microchip Tech (MCHP) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Microchip Technology (MCHP) reported $1.08 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 13.4%. EPS of $0.27 for the same period compares to $0.53 a
Here's What Key Metrics Tell Us About Expedia (EXPE) Q2 Earnings
Expedia (EXPE) reported $3.79 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 6.4%. EPS of $4.24 for the same period compares to $3.51 a year ago.
The
scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates
scPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.44 per share a year ago. These
Analog Devices (ADI) Ascends While Market Falls: Some Facts to Note
Analog Devices (ADI) closed at $223.15 in the latest trading session, marking a +1.12% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.08%. On the other hand, the Dow
Why Monolithic Power's Earnings and Guidance Ignited a Rally
Following its July 31st earnings announcement, shares of Monolithic Power Systems (NASDAQ: MPWR) jumped more than 10% in a single session on unusually high trading volume. In the first few
Take-Two Interactive (TTWO) Beats Q1 Earnings and Revenue Estimates
Take-Two Interactive (TTWO) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.05 per share a year ago
ePlus (PLUS) Tops Q1 Earnings and Revenue Estimates
ePlus (PLUS) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.13 per share a year ago. These figures are
Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates
Puma Biotech (PBYI) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to a loss of $0.05 per share a year ago. These figures
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates
OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.02 per share a year ago. These
Kratos (KTOS) Tops Q2 Earnings and Revenue Estimates
Kratos (KTOS) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.14 per share a year ago. These figures are
Integral Ad Science (IAS) Q2 Earnings and Revenues Beat Estimates
Integral Ad Science (IAS) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.05 per share a year ago. These
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Lags Revenue Estimates
Crinetics Pharmaceuticals, Inc. (CRNX) came out with a quarterly loss of $1.23 per share versus the Zacks Consensus Estimate of a loss of $1.13. This compares to a loss of $0.94 per share a year
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
Celldex Therapeutics (CLDX) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to a loss of $0.54 per share a year ago. These
Alta Equipment (ALTG) Reports Q2 Loss, Beats Revenue Estimates
Alta Equipment (ALTG) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.38 per share a year ago. These figures
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
Sutro Biopharma, Inc. (STRO) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.59 per share a year ago. These


